Open AccessIMMUNIZATION OF BRONCHOPULMONARY DYSPLASIA PATIENTS AGAINST RESPIRATORY PATHOGENS
Author(s) -
И. В. Давыдова,
Л.С. Намазова-Баранова,
М. В. Федосеенко,
К. А. Казакова,
Н. Е. Ткаченко,
Yu. S. Akoev
Publication year - 2019
Publication title -
rossijskij pediatričeskij žurnal
Language(s) - English
Resource type - Journals
eISSN - 2413-2918
pISSN - 1560-9561
DOI - 10.18821/1560-9561-2017-20-4-245-249
Subject(s) - bronchopulmonary dysplasia , medicine , palivizumab , immunization , pulmonology , pediatrics , respiratory system , intensive care medicine , immunology , gestational age , pregnancy , immune system , genetics , biology
Prevention of exacerbations of bronchopulmonary dysplasia (BPD) directly affects the outcome of the disease and belongs to the priority areas of pulmonology of early childhood age. Seasonal immunoprophylaxis of the severe course of respiratory syncytial viral infection (RSVI) with palivizumab and vaccine prophylaxis of pneumococcal and hemophilic infections in children who have formed BPD has been established to allow to reduce the frequency of hospitalization, resuscitation and death. The authors present their own data on results of passive and active immunization of BPD children against pathogens of the respiratory spectrum.